<SEC-DOCUMENT>0001179110-19-007236.txt : 20190605
<SEC-HEADER>0001179110-19-007236.hdr.sgml : 20190605
<ACCEPTANCE-DATETIME>20190605183837
ACCESSION NUMBER:		0001179110-19-007236
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20190603
FILED AS OF DATE:		20190605
DATE AS OF CHANGE:		20190605

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Wainer Andrea F
		CENTRAL INDEX KEY:			0001778070

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-02189
		FILM NUMBER:		19881142

	MAIL ADDRESS:	
		STREET 1:		100 ABBOTT PARK ROAD
		CITY:			ABBOTT PARK
		STATE:			IL
		ZIP:			60064

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ABBOTT LABORATORIES
		CENTRAL INDEX KEY:			0000001800
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				360698440
		STATE OF INCORPORATION:			IL
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		100 ABBOTT PARK ROAD
		CITY:			ABBOTT PARK
		STATE:			IL
		ZIP:			60064-3500
		BUSINESS PHONE:		2246676100

	MAIL ADDRESS:	
		STREET 1:		100 ABBOTT PARK ROAD
		CITY:			ABBOTT PARK
		STATE:			IL
		ZIP:			60064-3500
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>edgar.xml
<DESCRIPTION>FORM 3 -
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0206</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2019-06-03</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0000001800</issuerCik>
        <issuerName>ABBOTT LABORATORIES</issuerName>
        <issuerTradingSymbol>ABT</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001778070</rptOwnerCik>
            <rptOwnerName>Wainer Andrea F</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>100 ABBOTT PARK ROAD</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>ABBOTT PARK</rptOwnerCity>
            <rptOwnerState>IL</rptOwnerState>
            <rptOwnerZipCode>60064</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>Executive Vice President</officerTitle>
            <otherText></otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeHolding>
            <securityTitle>
                <value>Common shares without par value</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>30481</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
    </nonDerivativeTable>

    <derivativeTable>
        <derivativeHolding>
            <securityTitle>
                <value>Option (right to buy)</value>
                <footnoteId id="F1"/>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>47</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <value>2016-02-20</value>
            </exerciseDate>
            <expirationDate>
                <value>2025-02-19</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common shares</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>47226</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Option (right to buy)</value>
                <footnoteId id="F2"/>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>38.40</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <value>2017-02-19</value>
            </exerciseDate>
            <expirationDate>
                <value>2026-02-18</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common shares</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>75000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Option (right to buy)</value>
                <footnoteId id="F3"/>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>44.40</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <value>2018-02-17</value>
            </exerciseDate>
            <expirationDate>
                <value>2027-02-16</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common shares</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>53271</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Option (right to buy)</value>
                <footnoteId id="F4"/>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>59.94</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <value>2019-02-16</value>
            </exerciseDate>
            <expirationDate>
                <value>2028-02-15</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common shares</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>64449</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Option (right to buy)</value>
                <footnoteId id="F5"/>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>75.90</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <value>2020-02-22</value>
            </exerciseDate>
            <expirationDate>
                <value>2029-02-21</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common shares</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>47738</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.  The option became exercisable in annual increments of 15,742 on February 20, 2016, 15,742 on February 20, 2017, and 15,742 on February 20, 2018.</footnote>
        <footnote id="F2">Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.  The option became exercisable in annual increments of 25,000 on February 19, 2017, 25,000 on February 19, 2018, and 25,000 on February 19, 2019.</footnote>
        <footnote id="F3">Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.  The option became exercisable in annual increments of 17,757 and 17,757 on February 17, 2018 and February 17, 2019, respectively, and an increment of 17,757 becomes exercisable on February 17, 2020.</footnote>
        <footnote id="F4">Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.  The option became exercisable in an annual increment of 21,483 on February 16, 2019, and annual increments of 21,483 and 21,483 become exercisable on February 16, 2020 and February 16, 2021, respectively.</footnote>
        <footnote id="F5">Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 15,912 on February 22, 2020, 15,913 on February 22, 2021, and 15,913 on February 22, 2022.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>Jessica H. Paik, by power of attorney for Andrea F. Wainer</signatureName>
        <signatureDate>2019-06-05</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24
<SEQUENCE>2
<FILENAME>ex24wainer.txt
<TEXT>
Exhibit 24.1


POWER OF ATTORNEY


The undersigned constitutes and appoints HUBERT L. ALLEN, JESSICA
H. PAIK, and AARON N. RICE, and each of them individually, as the
undersigned's true and lawful attorney-in-fact and agent, with
full power of substitution and re-substitution, for the
undersigned and in the undersigned's name, place and stead,
to prepare and sign any and all Securities and Exchange Commission
("SEC") Notices of Proposed Sales of Securities pursuant to Rule 144
under the Securities Act of 1933 on Form 144, all SEC statements
on Forms 3, 4 and 5 as required under Section 16(a) of the Securities
Exchange Act of 1934, including a Form ID and any other documents
necessary to obtain codes and passwords necessary to make electronic
filings, and any amendments to such forms, and to file the same with
all exhibits thereto, and other documents in connection therewith,
with the SEC, granting unto said attorney-in-fact and agent full
power and authority to do and perform each act and thing requisite,
necessary or desirable to be done under said Rule 144 and Section
16(a), as fully for all intents and purposes as the undersigned
might or could do in person, hereby ratifying and confirming all
that said attorney-in-fact and agent may lawfully do or cause to be
done by virtue hereof.

A copy of this power of attorney shall be filed with the SEC.  The
authorization set forth above shall continue in full force and effect
until the undersigned is no longer required to file Forms 144, 3, 4, or
5 or if earlier, until the undersigned revokes such authorization by
written instructions to the attorney-in-fact.



Date:  May 28, 2019

/s/ Andrea F. Wainer
Signature of Reporting Person

Andrea F. Wainer


Abbott Laboratories
100 Abbott Park Road
Abbott Park, IL 60064


</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
